22 completed, 6 unknown, 4 active not recruiting, 2 recruiting. 36 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 36 | Completed 22, Unknown 6, Active not recruiting 4, Recruiting 2, Terminated 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Bleomycin Sulfate: new trials by email Literature Review of Bleomycin Sulfate trials Research Report on Bleomycin Sulfate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab Biospecimen Collection, Bleomycin Sulfate, Brentuximab Vedotin - Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 | Phase 3 | Recruiting | National Cancer Institute (NCI) | 1875 | 2023-05-11 | 2026-10-29 |
| Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors Best Practice, Biopsy Procedure, Biospecimen Collection - Childhood Extracranial Germ Cell Tumor, Extragonadal Embryonal Carcinoma | Phase 3 | Recruiting | Children's Oncology Group | 1780 | 2017-05-25 | 2026-08-25 |
| Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma Bleomycin Sulfate, Brentuximab Vedotin, Cyclophosphamide - Ann Arbor Stage IIB Hodgkin Lymphoma, Ann Arbor Stage IIIB Hodgkin Lymphoma | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 600 | 2015-03-19 | 2026-10-01 |
| Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma bleomycin sulfate, doxorubicin hydrochloride, liposomal vincristine sulfate - Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma | Phase 3 | Completed | Children's Oncology Group | 166 | 2009-12-07 | 2022-04-28 |
| Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma bleomycin sulfate, filgrastim, pegfilgrastim - Lymphoma | Phase 3 | Completed | University College, London | 1202 | 2008-08-29 | 2024-05-08 |
| Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma bleomycin sulfate, ABVD regimen, carmustine - Lymphoma | Phase 3 | Terminated | French Innovative Leukemia Organisation | 442 | 2008-05-01 | 2016-09-16 |
| Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors bleomycin sulfate, carboplatin, cisplatin - Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor | Phase 3 | Unknown | Children's Cancer and Leukaemia Group | 105 | 2005-05-01 | 2013-09-17 |
| Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors bleomycin sulfate, cisplatin, etoposide - Extragonadal Germ Cell Tumor, Teratoma | Phase 3 | Completed | UNICANCER | 263 | 2003-11-26 | 2025-02-06 |
| Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors conventional surgery, cisplatin, etoposide - Childhood Embryonal Tumor, Childhood Extracranial Germ Cell Tumor | Phase 3 | Completed | Children's Oncology Group | 302 | 2003-11-03 | 2021-07-13 |
| Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles bleomycin sulfate, cisplatin, etoposide - Drug/Agent Toxicity by Tissue/Organ, Testicular Germ Cell Tumor | Phase 3 | Completed | Queen Mary University of London | 210 | 2003-07-01 | 2013-08-12 |
| Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease Bleomycin Sulfate, Cisplatin, Cyclophosphamide - Childhood Lymphocyte-Depleted Classical Hodgkin Lymphoma, Childhood Mixed Cellularity Classical Hodgkin Lymphoma | Phase 3 | Completed | Children's Oncology Group | 1734 | 2002-09-01 | 2017-04-12 |
| Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma bleomycin sulfate, filgrastim, pegfilgrastim - Lymphoma | Phase 3 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 552 | 2002-08-01 | 2025-08-05 |
| Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy Filgrastim SD/01, Adriamycin, Bleomycin - Hodgkin Disease | Phase 3 | Completed | M.D. Anderson Cancer Center | 25 | 2001-11-01 | 2018-10-31 |
| Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma bleomycin sulfate, ABVD regimen, Stanford V regimen - Lymphoma | Phase 3 | Unknown | Mount Vernon Cancer Centre at Mount Vernon Hospital | 850 | 2001-10-01 | 2013-09-20 |
| S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease bleomycin sulfate, carmustine, cyclophosphamide - Lymphoma | Phase 3 | Terminated | SWOG Cancer Research Network | 11 | 2000-04-01 | 2013-01-24 |
| Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer bleomycin sulfate, filgrastim, cisplatin - Mediastinal Cancer, Metastatic Cancer | Phase 3 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 222 | 1999-04-01 | 2012-09-24 |
| Combination Chemotherapy in Treating Men With Germ Cell Cancer bleomycin sulfate, filgrastim, cisplatin - Extragonadal Germ Cell Tumor, Teratoma | Phase 2 / Phase 3 | Unknown | European Organisation for Research and Treatment of Cancer - EORTC | 498 | 1998-10-01 | 2012-03-06 |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma bleomycin sulfate, ABVD regimen, BEACOPP regimen - Lymphoma | Phase 3 | Active not recruiting | European Organisation for Research and Treatment of Cancer - EORTC | 1649 | 1998-10-01 | 2025-08-05 |
| Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease bleomycin sulfate, ABVD regimen, chlorambucil - Lymphoma | Phase 3 | Completed | Medical Research Council | 800 | 1998-06-01 | 2013-12-04 |
| Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma bleomycin sulfate, CHOP regimen, cyclophosphamide - Lymphoma | Phase 3 | Completed | Lymphoma Trials Office | 310 | 1998-01-01 | 2013-06-26 |
Showing 20 of 36. Sign in to see all of them.
Lymphoma (15) · Hodgkin Disease (14) · Teratoma (7) · Testicular Neoplasms (7) · Endodermal Sinus Tumor (6) · Carcinoma, Embryonal (5) · Testicular Germ Cell Tumor (5) · Acquired Immunodeficiency Syndrome (4) · HIV Infections (4) · Lymphoma, Non-Hodgkin (4) · Lymphoma, Large B-Cell, Diffuse (3) · Lymphoma, Large-Cell, Immunoblastic (3) · Sarcoma, Kaposi (3) · Seminoma (3) · Cardiotoxicity (2)
European Organisation for Research and Treatment of Cancer - EORTC (7) · Children's Oncology Group (6) · M.D. Anderson Cancer Center (2) · Medical Research Council (2) · National Cancer Institute (NCI) (2) · Sequus Pharmaceuticals (2) · Cancer Research UK (1) · Children's Cancer and Leukaemia Group (1) · Eastern Cooperative Oncology Group (1) · French Innovative Leukemia Organisation (1) · Lymphoma Trials Office (1) · Memorial Sloan Kettering Cancer Center (1) · Mount Vernon Cancer Centre at Mount Vernon Hospital (1) · NCIC Clinical Trials Group (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (17) · United Kingdom (15) · Canada (10) · Australia (7) · Puerto Rico (7) · France (6) · Belgium (5) · Italy (5) · Netherlands (5) · Poland (5) · Switzerland (5) · New Zealand (4) · Slovakia (4) · Spain (4) · Germany (3)
Christophe Ferme (2) · H. Eghbali, MD (2) · Ralph M. Meyer, MD, FRCPC (2) · A. L Frazier (1) · AA Levine (1) · Anas Younes, MD (1) · Anna Sureda (1) · Anne Frazier, MD (1) · Barry W. Hancock, MD (1) · Bengt Glimelius, MD (1) · Cameron K. Tebbi, MD (1) · Christian Gisselbrecht, MD (1) · Cindy Schwartz, MD (1) · DJ Straus (1) · David C. Linch (1)
PMID 37505794, PMID 39969278, PMID 40135712, PMID 15837968, PMID 15936157, PMID 16314615, PMID 17097834, PMID 17235042, PMID 17846017, PMID 17989384, PMID 19584400, PMID 19828373, PMID 19875337, PMID 21059637, PMID 22149921, PMID 22689804, PMID 22911615, PMID 24121121, PMID 25311218, PMID 25456363, PMID 27114593, PMID 27332902, PMID 28601705, PMID 29229324, PMID 29296710, PMID 30220622, PMID 31355926, PMID 33512412, PMID 34662378, PMID 36322844, PMID 36868525, PMID 37783480, PMID 37883739, PMID 37947987, PMID 39058966, PMID 39058968, PMID 39167741, PMID 40700618, PMID 40990939, PMID 42848781, PMID 9187443
U10CA098543 (3), U10CA180886 (3), 2004 (1), 2005 (1), U10CA032102 (1)